Modeling the Impacts of Restrictive Formularies on Patients With HIV
Constraining access to HIV regimens can have significant implications for patients. This study examined the economic and health impacts of restrictive HIV formulary designs.
Estimating the Social Value of G-CSF Therapies in the United States
Granulocyte-colony stimulating factors (G-CSFs) reduce the risk of febrile neutropenia in patients with cancer. This study evaluates the clinical and nonclinical value associated with G-CSFs.
Costs and Spillover Effects of Private Insurers' Coverage of Hepatitis C Treatment
Expanding private-payer coverage of hepatitis C treatment may yield significant long-term cost savings for private payers, reduced costs to Medicare, and increased social value.
